Neuro-Oncology · 2013 · 102 citations · 19 references
MedicineOncologyRadiologyDiagnostic ImagingDiagnostic RadiologyNeuro-oncologyBrain ImagingBrain TumorsGlioblastomaMagnetic Resonance ImagingMedical ImagingTumor CharacterizationContrast EnhancementContrast Enhancement PatternsGlioblastoma Blood-brain BarrierGlioblastoma ImagingGlioblastoma PrognosisMagnetic ResonanceVolumetric Brain AnalysisWhite Matter Hyperintensity Markers
BACKGROUND: Subtypes of glioblastoma multiforme (GBM) based on genetic and molecular alterations are thought to cause alterations in anatomic MRI owing to downstream biological changes, such as edema production, blood-brain barrier breakdown, and necrosis. The purpose of the current study was to identify a potential relationship between imaging features and the mesenchymal (MES) GBM subtype, which has the worst patient prognosis. METHODS: MRIs from 46 patients with histologically confirmed GBM were retrospectively analyzed. The volume of contrast enhancement, regions of central necrosis, and hyperintensity of T2/fluid attenuated inversion recovery (FLAIR) were measured. Additionally, the ratio of T2/FLAIR hyperintense volume to the volume of contrast enhancement and necrosis was calculated. RESULTS: The volume of contrast enhancement, volume of central necrosis, combined volume of contrast enhancement and central necrosis, and the ratio of T2/FLAIR to contrast enhancement and necrosis were significantly different in MES compared with non-MES GBM (Mann-Whitney, P < .05). Receiver-operator characteristics indicated that these 4 metrics were all significant predictors of the MES phenotype. The volume ratio of T2 hyperintensity to contrast enhancement and central necrosis was significantly lower in MES vs non-MES GBM (P < .0001), was a significant predictor of the MES phenotype (area under the curve = 0.93, P < .001), and could be used to stratify short- and long-term overall survival (log-rank, P = .0064 using cutoff of 3.0). These trends were also present when excluding isocitrate dehydrogenase 1 mutant tumors and incorporating covariates such as age and KPS score. CONCLUSIONS: Results suggest that volume ratio may be a simple, cost-effective, and noninvasive biomarker for quickly identifying MES GBM.
19
Roel G.W. Verhaak, Katherine A. Hoadley, Elizabeth Purdom et al. · Cancer Cell · 2010 · 7.7K citations · Full text
Gene Expression Profiling of Gliomas Strongly Predicts Survival
William A. Freije, F. Edmundo Castro-Vargas, Zixing Fang et al. · Cancer Research · 2004 · 740 citations · Full text
Decoding global gene expression programs in liver cancer by noninvasive imaging
Eran Segal, Claude B. Sirlin, Clara Ooi et al. · Nature Biotechnology · 2007 · 634 citations